glycyl-arginyl-glycyl-aspartyl-serine and Liver Dysfunction

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Liver Dysfunction in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Everhart, LM; Lavik, EB; Shick, AM; Shoffstall, AJ; Soehnlen, ES; Ustin, JS; Varley, ME	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Liver Dysfunction

Article	Year
Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma. Biomacromolecules, 2013, Aug-12, Volume: 14, Issue:8 Topics: Administration, Intravenous; Animals; Hemorrhage; Hemostatics; Ligands; Liver; Liver Diseases; Nanoparticles; Oligopeptides; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Thrombelastography; Tissue Distribution; Wounds, Nonpenetrating	2013

Article

Year

Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma.

Biomacromolecules, 2013, Aug-12, Volume: 14, Issue:8

Topics: Administration, Intravenous; Animals; Hemorrhage; Hemostatics; Ligands; Liver; Liver Diseases; Nanoparticles; Oligopeptides; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Thrombelastography; Tissue Distribution; Wounds, Nonpenetrating

2013